adMare BioInnovations - About the company
adMare BioInnovations is a funded company based in Vancouver (Canada), founded in 2019. It operates as a Provider of biopharma consulting services. adMare BioInnovations has raised an undisclosed amount in funding. The company has 145 active competitors, including 1 funded and 3 that have exited. Its top competitors include companies like Gradient, Bioassay and Lupus Research.
Company Details
- Website
- www.admarebio.com/en/
Key Metrics
Founded Year
2019
Location
Vancouver, Canada
Stage
Funding Raised
Latest Funding Round
Ranked
1st among 145 active competitors
Employee Count
49 as on Mar 31, 2026
Sign up to download adMare BioInnovations' company profile
adMare BioInnovations's funding and investors
adMare BioInnovations has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Mar 30, 2022 for $*****. 1 investor participated in its latest round. adMare BioInnovations has 1 institutional investor.
Here is the list of recent funding rounds of adMare BioInnovations:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 30, 2022 | 9716385 | Grant (prize money) | 2113895 | 4879253 | 2261013 | 5924814 |
View details of adMare BioInnovations's funding rounds and investors
adMare BioInnovations' founders and board of directors
Founder? Claim ProfileadMare BioInnovations' employee count trend
adMare BioInnovations has 49 employees as of Mar 26. Here is adMare BioInnovations's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
adMare BioInnovations's Competitors and alternates
Top competitors of adMare BioInnovations include Gradient, Bioassay and Lupus Research. Here is the list of Top 10 competitors of adMare BioInnovations, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | adMare BioInnovations 2019, Vancouver (Canada), Funding Raised | Provider of biopharma consulting services | - | 42/100 | |
2nd | Gradient 1985, Concord (United States), Early Stage | Environmental and risk science consulting firm providing trusted scientific analysis | $850K | - | 38/100 |
3rd | Specializes in biological assays | - | - | 38/100 | |
4th | Lupus Research 2016, New York City (United States), Unfunded | Dedicated to accelerating lupus research, treatment, and finding a cure | - | - | 36/100 |
5th | Interface 2004, Yeadon (United Kingdom), Unfunded | Provider of clinical services through pharmacists for the NHS and industry | - | - | 32/100 |
6th | Provider of Systems Biology solutions to industry and academia | - | 29/100 | ||
7th | Preclinical GPS 2009, Bainbridge Island (United States), Unfunded | Expert nonclinical development programs for biotech companies, from concept to execution | - | - | 29/100 |
8th | Crozet BioPharma 2017, Ayer (United States), Unfunded | Accelerating biological product development for human disease prevention and treatment | - | - | 28/100 |
9th | Glen Clova Scientific 2022, Glasgow (United Kingdom), Seed | Developer of biologic drugs for chronic inflammatory conditions | $4.96M | 27/100 | |
10th | Canadian, independent, drug development company for the portfolio of Sanderling Ventures | - | - | 26/100 |
Looking for more details on adMare BioInnovations's competitors? Click here to see the top ones
adMare BioInnovations's Investments and acquisitions
adMare BioInnovations has not made any acquisitions yet. adMare BioInnovations has made 14 investments.Here is the list of latest three $investments:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Feb 10, 2026 | Investments | 2008 | Montreal (Canada) | |
Oct 24, 2024 | Investments | 2021 | Cambridge (United Kingdom) | |
Oct 2024 | Investments | 2009 | Montreal (Canada) |
See all investments by adMare BioInnovations
News related to adMare BioInnovations
Media has covered adMare BioInnovations for a total of 4 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
Kainova Therapeutics Secures $32M CAD to Accelerate Therapy DevelopmentBenzinga•Feb 10, 2026•Invest Quebec, KainovaTX, Turenne Groupe, Schroders Capital and 8 others
•
•
AbbVie and adMare BioInnovations Launch Biotech Innovators Award in QuebecGlobeNewswire•Nov 25, 2025•adMare BioInnovations, AbbVie, OSE Immunotherapeutics
•
•
adMare BioInnovations Expands with New Wet Laboratory Space in VancouverBusiness Wire•Jun 28, 2024•adMare BioInnovations
•
•
Abdera raises funds to advance radiopharmaceuticals to treat cancerPharmaceutical Technology•Apr 20, 2023•Abdera Therapeutics, VenBio, Versant Ventures, Viking Global Investors and 6 others
•
MaRS partners with adMare BioInnovations to develop Therapeutics AcceleratoradMare BioInnovations•Feb 27, 2023•MaRS Discovery District, adMare BioInnovations
•
Inversago Pharma completes CAD $95 million Series C financing roundBusiness Wire•Oct 17, 2022•Inversago Pharma, New Enterprise Associates, Forbion, Amgen and 5 others
•
Are you a Founder ?
FAQs about adMare BioInnovations
Explore our recently published companies